Immunic to Host Virtual Progressive Multiple Sclerosis R&D Day on November 5, 2026

Article summary

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced that it will host a virtual Research and Development (R&D) Day focused on progressive...